Skip to main content Accesibility Help
×
×
Home

Activation syndrome caused by paroxetine in a cancer patient

  • Tomomi Nishida (a1), Makoto Wada (a1), Mei Wada (a1), Hiroshi Ito (a2), Masaru Narabayashi (a2) and Hideki Onishi (a1)...
Abstract

Individuals with cancer have two to four times an increased risk of depressive disorders compared to the general population. Depressive symptoms are related to impaired daily life functioning and a rise in health care utilization. Pharmacological treatments for depression are usually effective to reduce depressive symptoms, but sometimes lead to serious adverse reactions. We describe a cancer patient who developed sudden psychological and behavioral abnormalities after administration of the antidepressant paroxetine. Impulsive and aggressive symptoms are a so-called activation syndrome that can cause violent or suicidal tendencies. Palliative care staff should pay close attention to these potentially lethal reactions and make an immediate and correct diagnosis.

Copyright
Corresponding author
Address correspondence and reprint requests to: Tomomi Nishida, Department of Psycho-oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka city, Saitama 350-1298, Japan. E-mail: t-nishida@saitama-med.ac.jp
References
Hide All
Breggin, P.R. (2003/2004). Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis. International Journal of Risk & Safety in Medicine, 16, 3149.
Culpepper, L., Davidson, J.R.T., Dietrich, A.J., et al. (2004). Suicidality as a possible side effect of antidepressant treatment. Primary Care Companion Journal of Clinical Psychiatry, 6, 7986.
Leo, R.J. (1996). Movement disorders associated with the serotonin selective reuptake inhibitors. Journal of Clinical Psychiatry, 57, 449454.
Lipinski, J.F. Jr., Mallya, G., Zimmerman, P., et al. (1989). Fluoxetine-induced akathisia: Clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339342.
MacGillivray, S., Arroll, B., Hatcher, S., et al. (2003). Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: Systematic review and meta-analysis. British Medical Journal, 326, 10141017.
Rodin, G., Lloyd, N., Katz, M., et al. (2007). The treatment of depression in cancer patients: A systematic review. Supportive Care in Cancer, 15, 123136.
Teicher, M.H., Glod, C., & Cole, J.O. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207210.
Wagstaff, A.J., Cheer, S.M., Matheson, A.J., et al. (2002). Spotlight on paroxetine in psychiatric disorders in adults. CNS Drugs, 16, 425434.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Palliative & Supportive Care
  • ISSN: 1478-9515
  • EISSN: 1478-9523
  • URL: /core/journals/palliative-and-supportive-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed